Wells Fargo
LUNG icon

Wells Fargo’s Pulmonx LUNG Stock Holding History

Wells Fargo’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.86K Sell
5,275
-13,475
-72% -$18.6K ﹤0.01% 6162
2026
Q1 		$24.2K Sell
18,750
-28,830
-61% -$47.6K ﹤0.01% 5702
2025
Q4 		$105K Buy
47,580
+23,839
+100% +$44.8K ﹤0.01% 5371
2025
Q3 		$38.5K Buy
23,741
+3,721
+19% +$7.78K ﹤0.01% 5634
2025
Q2 		$51.9K Buy
20,020
+888
+5% +$3.5K ﹤0.01% 5491
2025
Q1 		$129K Buy
19,132
+714
+4% +$5.05K ﹤0.01% 4963
2024
Q4 		$125K Buy
18,418
+6,033
+49% +$39.7K ﹤0.01% 5073
2024
Q3 		$103K Sell
12,385
-18
-0.1% -$130 ﹤0.01% 5013
2024
Q2 		$78.6K Buy
12,403
+935
+8% +$7.19K ﹤0.01% 5084
2024
Q1 		$106K Buy
11,468
+1,133
+11% +$13.3K ﹤0.01% 4854
2023
Q4 		$132K Buy
10,335
+2,941
+40% +$30.6K ﹤0.01% 4736
2023
Q3 		$76.4K Sell
7,394
-13,978
-65% -$162K ﹤0.01% 4940
2023
Q2 		$280K Buy
21,372
+8,686
+68% +$106K ﹤0.01% 4363
2023
Q1 		$142K Buy
12,686
+12,381
+4,059% +$122K ﹤0.01% 4628
2022
Q4 		$2.57K Sell
305
-835
-73% -$7.94K ﹤0.01% 5948
2022
Q3 		$19K Sell
1,140
-918
-45% -$16.9K ﹤0.01% 5426
2022
Q2 		$30K Sell
2,058
-92,132
-98% -$1.9M ﹤0.01% 5271
2022
Q1 		$2.34M Sell
94,190
-3,553
-4% -$91.8K ﹤0.01% 3150
2021
Q4 		$3.13M Sell
97,743
-223,455
-70% -$8.16M ﹤0.01% 3047
2021
Q3 		$11.6M Buy
321,198
+37,998
+13% +$1.5M ﹤0.01% 2075
2021
Q2 		$12.5M Buy
283,200
+25,844
+10% +$1.13M ﹤0.01% 2055
2021
Q1 		$11.8M Sell
257,356
-12,491
-5% -$716K ﹤0.01% 2069
2020
Q4 		$18.6M Buy
+269,847
New +$13.2M ﹤0.01% 1610

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Wells Fargo's LUNG Position: Q2 2026 in Review

Wells Fargo reduced its Pulmonx (LUNG) stake by 72% in Q2 2026, selling an estimated $18.6K and leaving 5,275 shares worth $6.86K. The position accounts for ﹤0.01% of the portfolio, ranked #6162.

Wells Fargo first reported a position in LUNG in Q4 2020 and has held it in 23 quarters since. The position peaked at $18.6M in Q4 2020. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Wells Fargo held 5,275 shares of Pulmonx worth $6.86K as of Q2 2026.
  • Wells Fargo sold 13,475 Pulmonx shares in Q2 2026, an estimated $18.6K.
  • Pulmonx made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6162 holding.
  • Wells Fargo first reported a position in Pulmonx in Q4 2020 and has held it in 23 quarters since.
  • Wells Fargo's Pulmonx position peaked at $18.6M in Q4 2020.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.